Landscapes / Companies
Perspective Therapeutics not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 2
Drugs
3
in active trials · 4 in all
Trials
3 active
4 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 31 Dec 2027Phase 1/2 trial completes | |||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Recurrent Melanoma (Skin), Metastatic Melanoma and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Jan 2028Phase 1/2 trial completes | |||
| Next date | 31 Jan 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Pancreatic Ductal Adenocarcinoma, Gastric Cancer and 6 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 26 Nov 2029Phase 1/2 trial completes | |||
| Next date | 26 Nov 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Neuroendocrine Tumors Unresectable, Neuroendocrine Tumor Metastatic and 5 more | ||||
| Open drug page | |||||
About
- No active trial
- VMT02
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021